Strike Bio, Inc.
Records under this name other than the patents Strike Bio, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,808,983 | shRNA molecules and methods of use thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,758,998 | Construction of bifunctional short hairpin RNA Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,906,874 | Bi-functional shRNA targeting Stathmin 1 and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,181,225 | Targeted delivery using tissue-specific peptidomimetic ligands Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,353,373 | Bi-functional short-hairpin RNA (bi-shRNA) specific for single-nucleotide KRAS mutations Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,252,526 | ShRNA molecules and methods of use thereof Formerly held In force Term ended Nov 17, 2026 · USPTO record | In force | Term ended Nov 17, 2026 | USPTO record |
| US 8,735,058 | ShRNA molecules and methods of use thereof Formerly held In force Term ended Nov 17, 2026 · USPTO record | In force | Term ended Nov 17, 2026 | USPTO record |
| US 9,683,237 | Multiple Targeted Rnai for the Treatment of Cancers Formerly held Lapsed on the fee record Ended Jun 20, 2025 · Medium confidence | Lapsed on the fee record | Ended Jun 20, 2025 | Medium confidence |
| US 8,460,908 | Polypeptides Having Colanic Acid-Degrading Activity Formerly held Lapsed on the fee record Ended Jun 11, 2025 · High confidence | Lapsed on the fee record | Ended Jun 11, 2025 | High confidence |
| US 9,562,023 | Dipeptide mimics, libraries combining two dipeptide mimics with a third group, and methods for production thereof Formerly held Lapsed on the fee record Ended Feb 7, 2025 · USPTO record | Lapsed on the fee record | Ended Feb 7, 2025 | USPTO record |